Validity Gates Expose Limits of Longitudinal Multimodal Parkinson Disease Prediction
Multimodal Parkinson disease models can improve internally while obscuring why patients differ and whether a gain is deployable. We separated clinical trajectories, dated biological sources, observation process and cohort-relative, age-weighted evidence for dopaminergic, injury/glial, cognitive co-pathology and lysosom...